Camille L Bedrosian

RARE

Camille L Bedrosian serves as Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

12 trades

$1.97M

Net Position

Net Seller

$1.97M

Companies Traded

AMLX, RARE

Active Period

Apr 2021 – Dec 2025

12 total trades

Most Recent

Sell AMLX

Dec 1, 2025 · $94.4K

Camille L Bedrosian's Insider Trading at Ultragenyx Pharmaceutical Inc. (RARE)

Buys

0 · $0.00

Sells

7 · $1.59M

Total Shares Bought

Total Shares Sold

19,082

RARE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 3, 2023	Sell	3,881	$45.25	$175.6K	46,720
Mar 3, 2022	Sell	2,821	$66.62	$187.9K	33,938
Feb 1, 2022	Sell	1,657	$66.30	$109.9K	36,759
Oct 18, 2021	Sell	359	$81.14	$29.1K	38,416
Sep 2, 2021	Sell	5,000	$100.11	$500.5K	38,775
May 10, 2021	Sell	364	$113.67	$41.4K	38,775
Apr 19, 2021	Sell	5,000	$109.09	$545.5K	39,139

Camille L Bedrosian's Insider Trading at Amylyx Pharmaceuticals, Inc. (AMLX)

Buys

0 · $0.00

Sells

5 · $379.6K

Total Shares Bought

Total Shares Sold

47,907

AMLX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Dec 1, 2025	Sell	6,580	$14.35	$94.4K
Sep 30, 2025	Sell	12,039	$14.58	$175.5K
Mar 31, 2025	Sell	12,425	$3.47	$43.1K
Dec 2, 2024	Sell	5,421	$5.54	$30.0K
Sep 30, 2024	Sell	11,442	$3.20	$36.6K